nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1B—obesity	0.26	0.428	CbGaD
Methysergide—HTR2C—obesity	0.212	0.349	CbGaD
Methysergide—HTR2A—obesity	0.135	0.222	CbGaD
Methysergide—HTR7—sympathetic nervous system—obesity	0.00516	0.116	CbGeAlD
Methysergide—HTR7—vagus nerve—obesity	0.005	0.112	CbGeAlD
Methysergide—HTR7—autonomic nervous system—obesity	0.00347	0.0779	CbGeAlD
Methysergide—HTR2A—sympathetic nervous system—obesity	0.00322	0.0723	CbGeAlD
Methysergide—HTR2A—vagus nerve—obesity	0.00312	0.07	CbGeAlD
Methysergide—HTR2A—autonomic nervous system—obesity	0.00216	0.0486	CbGeAlD
Methysergide—HTR1A—hindbrain—obesity	0.00153	0.0343	CbGeAlD
Methysergide—HTR7—hindbrain—obesity	0.00146	0.0328	CbGeAlD
Methysergide—SIGMAR1—islet of Langerhans—obesity	0.00111	0.0248	CbGeAlD
Methysergide—Dyspepsia—Methamphetamine—obesity	0.00101	0.0066	CcSEcCtD
Methysergide—Insomnia—Benzphetamine—obesity	0.001	0.00654	CcSEcCtD
Methysergide—Gastrointestinal disorder—Methamphetamine—obesity	0.000994	0.00648	CcSEcCtD
Methysergide—Tachycardia—Phendimetrazine—obesity	0.000988	0.00644	CcSEcCtD
Methysergide—Constipation—Methamphetamine—obesity	0.000985	0.00642	CcSEcCtD
Methysergide—Dyspepsia—Benzphetamine—obesity	0.000978	0.00637	CcSEcCtD
Methysergide—Blood urea increased—Sibutramine—obesity	0.000968	0.00631	CcSEcCtD
Methysergide—Gastrointestinal disorder—Benzphetamine—obesity	0.000959	0.00625	CcSEcCtD
Methysergide—Urine output increased—Orlistat—obesity	0.000958	0.00624	CcSEcCtD
Methysergide—Insomnia—Phendimetrazine—obesity	0.000915	0.00596	CcSEcCtD
Methysergide—HTR2A—hindbrain—obesity	0.000912	0.0205	CbGeAlD
Methysergide—Alopecia—Diethylpropion—obesity	0.000895	0.00583	CcSEcCtD
Methysergide—HTR7—respiratory system—obesity	0.000893	0.02	CbGeAlD
Methysergide—HTR1B—cardiovascular system—obesity	0.000887	0.0199	CbGeAlD
Methysergide—Euphoric mood—Sibutramine—obesity	0.000881	0.00574	CcSEcCtD
Methysergide—SIGMAR1—adrenal cortex—obesity	0.000877	0.0197	CbGeAlD
Methysergide—Polyuria—Orlistat—obesity	0.000876	0.00571	CcSEcCtD
Methysergide—HTR2B—adrenal cortex—obesity	0.000875	0.0196	CbGeAlD
Methysergide—Constipation—Phendimetrazine—obesity	0.000866	0.00564	CcSEcCtD
Methysergide—Chest pain—Phentermine—obesity	0.000863	0.00562	CcSEcCtD
Methysergide—HTR1D—cardiovascular system—obesity	0.000859	0.0193	CbGeAlD
Methysergide—Alopecia—Cimetidine—obesity	0.000852	0.00555	CcSEcCtD
Methysergide—Tachycardia—Phenylpropanolamine—obesity	0.000844	0.0055	CcSEcCtD
Methysergide—Oedema—Phentermine—obesity	0.000827	0.00539	CcSEcCtD
Methysergide—Ill-defined disorder—Diethylpropion—obesity	0.000818	0.00533	CcSEcCtD
Methysergide—Urine output increased—Bupropion—obesity	0.000808	0.00527	CcSEcCtD
Methysergide—Tachycardia—Phentermine—obesity	0.000808	0.00526	CcSEcCtD
Methysergide—Abdominal pain—Phendimetrazine—obesity	0.0008	0.00521	CcSEcCtD
Methysergide—HTR2B—cardiovascular system—obesity	0.000799	0.0179	CbGeAlD
Methysergide—Malaise—Diethylpropion—obesity	0.000795	0.00518	CcSEcCtD
Methysergide—Diarrhoea—Methamphetamine—obesity	0.000788	0.00513	CcSEcCtD
Methysergide—Insomnia—Phenylpropanolamine—obesity	0.000782	0.00509	CcSEcCtD
Methysergide—Dyspnoea—Phenylpropanolamine—obesity	0.000771	0.00502	CcSEcCtD
Methysergide—Somnolence—Phenylpropanolamine—obesity	0.000769	0.00501	CcSEcCtD
Methysergide—Euphoric mood—Bupropion—obesity	0.000768	0.005	CcSEcCtD
Methysergide—Convulsion—Diethylpropion—obesity	0.000764	0.00498	CcSEcCtD
Methysergide—Dizziness—Methamphetamine—obesity	0.000762	0.00496	CcSEcCtD
Methysergide—Diarrhoea—Benzphetamine—obesity	0.00076	0.00495	CcSEcCtD
Methysergide—Malaise—Cimetidine—obesity	0.000757	0.00493	CcSEcCtD
Methysergide—Chest pain—Diethylpropion—obesity	0.000751	0.00489	CcSEcCtD
Methysergide—Myalgia—Diethylpropion—obesity	0.000751	0.00489	CcSEcCtD
Methysergide—Insomnia—Phentermine—obesity	0.000748	0.00487	CcSEcCtD
Methysergide—Pain in extremity—Sibutramine—obesity	0.000745	0.00485	CcSEcCtD
Methysergide—Discomfort—Diethylpropion—obesity	0.000742	0.00483	CcSEcCtD
Methysergide—Constipation—Phenylpropanolamine—obesity	0.000739	0.00482	CcSEcCtD
Methysergide—Polyuria—Bupropion—obesity	0.000739	0.00482	CcSEcCtD
Methysergide—Dizziness—Benzphetamine—obesity	0.000734	0.00478	CcSEcCtD
Methysergide—Dyspepsia—Phentermine—obesity	0.000728	0.00474	CcSEcCtD
Methysergide—Hyperaesthesia—Topiramate—obesity	0.000726	0.00473	CcSEcCtD
Methysergide—HTR1A—cardiovascular system—obesity	0.000716	0.0161	CbGeAlD
Methysergide—Arthralgia—Cimetidine—obesity	0.000714	0.00465	CcSEcCtD
Methysergide—Myalgia—Cimetidine—obesity	0.000714	0.00465	CcSEcCtD
Methysergide—Gastrointestinal disorder—Phentermine—obesity	0.000714	0.00465	CcSEcCtD
Methysergide—Mydriasis—Topiramate—obesity	0.000714	0.00465	CcSEcCtD
Methysergide—Fatigue—Phentermine—obesity	0.000713	0.00465	CcSEcCtD
Methysergide—Feeling abnormal—Phenylpropanolamine—obesity	0.000713	0.00464	CcSEcCtD
Methysergide—SIGMAR1—pituitary gland—obesity	0.000709	0.0159	CbGeAlD
Methysergide—Constipation—Phentermine—obesity	0.000708	0.00461	CcSEcCtD
Methysergide—SIGMAR1—adipose tissue—obesity	0.000706	0.0158	CbGeAlD
Methysergide—HTR2B—adipose tissue—obesity	0.000704	0.0158	CbGeAlD
Methysergide—Tachycardia—Diethylpropion—obesity	0.000703	0.00458	CcSEcCtD
Methysergide—Ataxia—Sibutramine—obesity	0.0007	0.00456	CcSEcCtD
Methysergide—Diarrhoea—Phendimetrazine—obesity	0.000693	0.00451	CcSEcCtD
Methysergide—HTR7—cardiovascular system—obesity	0.000684	0.0154	CbGeAlD
Methysergide—Orthostatic hypotension—Sibutramine—obesity	0.00068	0.00443	CcSEcCtD
Methysergide—Thrombocytopenia—Cimetidine—obesity	0.000671	0.00437	CcSEcCtD
Methysergide—Dizziness—Phendimetrazine—obesity	0.000669	0.00436	CcSEcCtD
Methysergide—Tachycardia—Cimetidine—obesity	0.000668	0.00435	CcSEcCtD
Methysergide—HTR2B—digestive system—obesity	0.000663	0.0149	CbGeAlD
Methysergide—Nausea—Benzphetamine—obesity	0.00066	0.0043	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Diethylpropion—obesity	0.000656	0.00427	CcSEcCtD
Methysergide—Abdominal pain—Phentermine—obesity	0.000654	0.00426	CcSEcCtD
Methysergide—Insomnia—Diethylpropion—obesity	0.000651	0.00424	CcSEcCtD
Methysergide—Pain in extremity—Bupropion—obesity	0.000649	0.00423	CcSEcCtD
Methysergide—Dyspnoea—Diethylpropion—obesity	0.000642	0.00418	CcSEcCtD
Methysergide—Somnolence—Diethylpropion—obesity	0.00064	0.00417	CcSEcCtD
Methysergide—Eosinophilia—Sibutramine—obesity	0.000637	0.00415	CcSEcCtD
Methysergide—Dyspepsia—Diethylpropion—obesity	0.000634	0.00413	CcSEcCtD
Methysergide—SIGMAR1—adrenal gland—obesity	0.000633	0.0142	CbGeAlD
Methysergide—HTR2B—adrenal gland—obesity	0.000632	0.0142	CbGeAlD
Methysergide—Musculoskeletal discomfort—Cimetidine—obesity	0.000624	0.00406	CcSEcCtD
Methysergide—Gastrointestinal disorder—Diethylpropion—obesity	0.000621	0.00405	CcSEcCtD
Methysergide—Oliguria—Topiramate—obesity	0.000618	0.00403	CcSEcCtD
Methysergide—Constipation—Diethylpropion—obesity	0.000616	0.00401	CcSEcCtD
Methysergide—Ataxia—Bupropion—obesity	0.00061	0.00398	CcSEcCtD
Methysergide—Somnolence—Cimetidine—obesity	0.000609	0.00397	CcSEcCtD
Methysergide—HTR1B—endocrine gland—obesity	0.000608	0.0137	CbGeAlD
Methysergide—Dysuria—Sibutramine—obesity	0.000602	0.00392	CcSEcCtD
Methysergide—Nausea—Phendimetrazine—obesity	0.000601	0.00392	CcSEcCtD
Methysergide—Asthenia—Phentermine—obesity	0.000594	0.00387	CcSEcCtD
Methysergide—Feeling abnormal—Diethylpropion—obesity	0.000593	0.00386	CcSEcCtD
Methysergide—Orthostatic hypotension—Bupropion—obesity	0.000593	0.00386	CcSEcCtD
Methysergide—Fatigue—Cimetidine—obesity	0.00059	0.00385	CcSEcCtD
Methysergide—Constipation—Cimetidine—obesity	0.000586	0.00382	CcSEcCtD
Methysergide—Weight increased—Sibutramine—obesity	0.000586	0.00381	CcSEcCtD
Methysergide—Dizziness—Phenylpropanolamine—obesity	0.000572	0.00372	CcSEcCtD
Methysergide—HTR7—digestive system—obesity	0.000568	0.0127	CbGeAlD
Methysergide—HTR1A—adrenal gland—obesity	0.000566	0.0127	CbGeAlD
Methysergide—Diarrhoea—Phentermine—obesity	0.000566	0.00369	CcSEcCtD
Methysergide—Feeling abnormal—Cimetidine—obesity	0.000564	0.00368	CcSEcCtD
Methysergide—HTR2A—respiratory system—obesity	0.000557	0.0125	CbGeAlD
Methysergide—Vomiting—Phenylpropanolamine—obesity	0.00055	0.00358	CcSEcCtD
Methysergide—Dizziness—Phentermine—obesity	0.000547	0.00356	CcSEcCtD
Methysergide—Rash—Phenylpropanolamine—obesity	0.000545	0.00355	CcSEcCtD
Methysergide—Dermatitis—Phenylpropanolamine—obesity	0.000545	0.00355	CcSEcCtD
Methysergide—Body temperature increased—Cimetidine—obesity	0.000541	0.00353	CcSEcCtD
Methysergide—HTR7—adrenal gland—obesity	0.000541	0.0121	CbGeAlD
Methysergide—Vomiting—Phentermine—obesity	0.000526	0.00343	CcSEcCtD
Methysergide—Dysuria—Bupropion—obesity	0.000525	0.00342	CcSEcCtD
Methysergide—Oedema peripheral—Orlistat—obesity	0.000524	0.00342	CcSEcCtD
Methysergide—Rash—Phentermine—obesity	0.000522	0.0034	CcSEcCtD
Methysergide—Dermatitis—Phentermine—obesity	0.000521	0.0034	CcSEcCtD
Methysergide—Urine output increased—Topiramate—obesity	0.000515	0.00336	CcSEcCtD
Methysergide—Nausea—Phenylpropanolamine—obesity	0.000514	0.00335	CcSEcCtD
Methysergide—Weight increased—Bupropion—obesity	0.000511	0.00333	CcSEcCtD
Methysergide—Weight decreased—Bupropion—obesity	0.000508	0.00331	CcSEcCtD
Methysergide—Oedema peripheral—Sibutramine—obesity	0.000507	0.00331	CcSEcCtD
Methysergide—SIGMAR1—liver—obesity	0.000495	0.0111	CbGeAlD
Methysergide—Methylergometrine—DRD1—obesity	0.000493	0.074	CrCbGaD
Methysergide—Diarrhoea—Diethylpropion—obesity	0.000492	0.00321	CcSEcCtD
Methysergide—Nausea—Phentermine—obesity	0.000491	0.0032	CcSEcCtD
Methysergide—Asthenia—Cimetidine—obesity	0.000491	0.0032	CcSEcCtD
Methysergide—HTR1A—endocrine gland—obesity	0.000491	0.011	CbGeAlD
Methysergide—Euphoric mood—Topiramate—obesity	0.000489	0.00319	CcSEcCtD
Methysergide—Ergonovine—HTR2C—obesity	0.000483	0.0725	CrCbGaD
Methysergide—Dizziness—Diethylpropion—obesity	0.000476	0.0031	CcSEcCtD
Methysergide—Polyuria—Topiramate—obesity	0.000471	0.00307	CcSEcCtD
Methysergide—Alopecia—Orlistat—obesity	0.00047	0.00306	CcSEcCtD
Methysergide—HTR7—endocrine gland—obesity	0.000469	0.0105	CbGeAlD
Methysergide—Diarrhoea—Cimetidine—obesity	0.000469	0.00305	CcSEcCtD
Methysergide—Vomiting—Diethylpropion—obesity	0.000458	0.00298	CcSEcCtD
Methysergide—Alopecia—Sibutramine—obesity	0.000455	0.00296	CcSEcCtD
Methysergide—Rash—Diethylpropion—obesity	0.000454	0.00296	CcSEcCtD
Methysergide—Dermatitis—Diethylpropion—obesity	0.000453	0.00295	CcSEcCtD
Methysergide—Dizziness—Cimetidine—obesity	0.000453	0.00295	CcSEcCtD
Methysergide—Back pain—Orlistat—obesity	0.000448	0.00292	CcSEcCtD
Methysergide—Oedema peripheral—Bupropion—obesity	0.000442	0.00288	CcSEcCtD
Methysergide—Vomiting—Cimetidine—obesity	0.000435	0.00284	CcSEcCtD
Methysergide—Back pain—Sibutramine—obesity	0.000434	0.00283	CcSEcCtD
Methysergide—Rash—Cimetidine—obesity	0.000432	0.00281	CcSEcCtD
Methysergide—Dermatitis—Cimetidine—obesity	0.000431	0.00281	CcSEcCtD
Methysergide—Ill-defined disorder—Orlistat—obesity	0.00043	0.0028	CcSEcCtD
Methysergide—Nausea—Diethylpropion—obesity	0.000428	0.00279	CcSEcCtD
Methysergide—HTR2A—cardiovascular system—obesity	0.000427	0.00957	CbGeAlD
Methysergide—HTR7—liver—obesity	0.000423	0.00949	CbGeAlD
Methysergide—Methylergometrine—HTR2C—obesity	0.000422	0.0633	CrCbGaD
Methysergide—Malaise—Orlistat—obesity	0.000418	0.00272	CcSEcCtD
Methysergide—Flushing—Bupropion—obesity	0.000417	0.00271	CcSEcCtD
Methysergide—Ill-defined disorder—Sibutramine—obesity	0.000416	0.00271	CcSEcCtD
Methysergide—Pain in extremity—Topiramate—obesity	0.000414	0.00269	CcSEcCtD
Methysergide—Nausea—Cimetidine—obesity	0.000407	0.00265	CcSEcCtD
Methysergide—Malaise—Sibutramine—obesity	0.000404	0.00263	CcSEcCtD
Methysergide—Convulsion—Orlistat—obesity	0.000401	0.00261	CcSEcCtD
Methysergide—Alopecia—Bupropion—obesity	0.000397	0.00258	CcSEcCtD
Methysergide—Chest pain—Orlistat—obesity	0.000394	0.00257	CcSEcCtD
Methysergide—Myalgia—Orlistat—obesity	0.000394	0.00257	CcSEcCtD
Methysergide—Lisuride—DRD4—obesity	0.000391	0.0587	CrCbGaD
Methysergide—Discomfort—Orlistat—obesity	0.00039	0.00254	CcSEcCtD
Methysergide—Ataxia—Topiramate—obesity	0.000389	0.00253	CcSEcCtD
Methysergide—Convulsion—Sibutramine—obesity	0.000388	0.00253	CcSEcCtD
Methysergide—Arthralgia—Sibutramine—obesity	0.000382	0.00249	CcSEcCtD
Methysergide—Chest pain—Sibutramine—obesity	0.000382	0.00249	CcSEcCtD
Methysergide—Myalgia—Sibutramine—obesity	0.000382	0.00249	CcSEcCtD
Methysergide—Oedema—Orlistat—obesity	0.000378	0.00246	CcSEcCtD
Methysergide—Back pain—Bupropion—obesity	0.000378	0.00246	CcSEcCtD
Methysergide—HTR2A—pituitary gland—obesity	0.000378	0.00848	CbGeAlD
Methysergide—Orthostatic hypotension—Topiramate—obesity	0.000378	0.00246	CcSEcCtD
Methysergide—Discomfort—Sibutramine—obesity	0.000377	0.00246	CcSEcCtD
Methysergide—Oedema—Sibutramine—obesity	0.000366	0.00238	CcSEcCtD
Methysergide—Ill-defined disorder—Bupropion—obesity	0.000363	0.00236	CcSEcCtD
Methysergide—Bromocriptine—DRD4—obesity	0.000362	0.0544	CrCbGaD
Methysergide—Thrombocytopenia—Sibutramine—obesity	0.000358	0.00233	CcSEcCtD
Methysergide—Tachycardia—Sibutramine—obesity	0.000357	0.00233	CcSEcCtD
Methysergide—HTR2A—digestive system—obesity	0.000354	0.00795	CbGeAlD
Methysergide—Eosinophilia—Topiramate—obesity	0.000354	0.00231	CcSEcCtD
Methysergide—Malaise—Bupropion—obesity	0.000353	0.0023	CcSEcCtD
Methysergide—Lisuride—HTR1B—obesity	0.000347	0.0521	CrCbGaD
Methysergide—Musculoskeletal discomfort—Orlistat—obesity	0.000344	0.00224	CcSEcCtD
Methysergide—Insomnia—Orlistat—obesity	0.000342	0.00223	CcSEcCtD
Methysergide—Paraesthesia—Orlistat—obesity	0.00034	0.00221	CcSEcCtD
Methysergide—Convulsion—Bupropion—obesity	0.000339	0.00221	CcSEcCtD
Methysergide—HTR2A—adrenal gland—obesity	0.000337	0.00757	CbGeAlD
Methysergide—Dysuria—Topiramate—obesity	0.000334	0.00218	CcSEcCtD
Methysergide—Neutropenia—Topiramate—obesity	0.000334	0.00218	CcSEcCtD
Methysergide—Ergotamine—HTR1B—obesity	0.000333	0.0501	CrCbGaD
Methysergide—Musculoskeletal discomfort—Sibutramine—obesity	0.000333	0.00217	CcSEcCtD
Methysergide—Dyspepsia—Orlistat—obesity	0.000333	0.00217	CcSEcCtD
Methysergide—Myalgia—Bupropion—obesity	0.000333	0.00217	CcSEcCtD
Methysergide—Chest pain—Bupropion—obesity	0.000333	0.00217	CcSEcCtD
Methysergide—Arthralgia—Bupropion—obesity	0.000333	0.00217	CcSEcCtD
Methysergide—Insomnia—Sibutramine—obesity	0.000331	0.00216	CcSEcCtD
Methysergide—Lisuride—DRD1—obesity	0.000331	0.0497	CrCbGaD
Methysergide—Discomfort—Bupropion—obesity	0.000329	0.00214	CcSEcCtD
Methysergide—Paraesthesia—Sibutramine—obesity	0.000329	0.00214	CcSEcCtD
Methysergide—Gastrointestinal disorder—Orlistat—obesity	0.000326	0.00213	CcSEcCtD
Methysergide—Dyspnoea—Sibutramine—obesity	0.000326	0.00213	CcSEcCtD
Methysergide—Fatigue—Orlistat—obesity	0.000326	0.00212	CcSEcCtD
Methysergide—Somnolence—Sibutramine—obesity	0.000325	0.00212	CcSEcCtD
Methysergide—Weight increased—Topiramate—obesity	0.000325	0.00212	CcSEcCtD
Methysergide—Weight decreased—Topiramate—obesity	0.000323	0.00211	CcSEcCtD
Methysergide—Pain—Orlistat—obesity	0.000323	0.00211	CcSEcCtD
Methysergide—Dyspepsia—Sibutramine—obesity	0.000322	0.0021	CcSEcCtD
Methysergide—Bromocriptine—HTR1B—obesity	0.000322	0.0483	CrCbGaD
Methysergide—Oedema—Bupropion—obesity	0.000319	0.00208	CcSEcCtD
Methysergide—Gastrointestinal disorder—Sibutramine—obesity	0.000316	0.00206	CcSEcCtD
Methysergide—Pain—Sibutramine—obesity	0.000313	0.00204	CcSEcCtD
Methysergide—Constipation—Sibutramine—obesity	0.000313	0.00204	CcSEcCtD
Methysergide—Thrombocytopenia—Bupropion—obesity	0.000312	0.00203	CcSEcCtD
Methysergide—Feeling abnormal—Orlistat—obesity	0.000312	0.00203	CcSEcCtD
Methysergide—Tachycardia—Bupropion—obesity	0.000311	0.00203	CcSEcCtD
Methysergide—Gastrointestinal pain—Orlistat—obesity	0.000309	0.00201	CcSEcCtD
Methysergide—Lisuride—ADRB1—obesity	0.000307	0.0461	CrCbGaD
Methysergide—Bromocriptine—DRD1—obesity	0.000306	0.046	CrCbGaD
Methysergide—Feeling abnormal—Sibutramine—obesity	0.000302	0.00196	CcSEcCtD
Methysergide—Gastrointestinal pain—Sibutramine—obesity	0.000299	0.00195	CcSEcCtD
Methysergide—Abdominal pain—Orlistat—obesity	0.000299	0.00195	CcSEcCtD
Methysergide—Body temperature increased—Orlistat—obesity	0.000299	0.00195	CcSEcCtD
Methysergide—HTR2A—endocrine gland—obesity	0.000293	0.00657	CbGeAlD
Methysergide—Musculoskeletal discomfort—Bupropion—obesity	0.000291	0.00189	CcSEcCtD
Methysergide—Body temperature increased—Sibutramine—obesity	0.000289	0.00188	CcSEcCtD
Methysergide—Abdominal pain—Sibutramine—obesity	0.000289	0.00188	CcSEcCtD
Methysergide—Insomnia—Bupropion—obesity	0.000289	0.00188	CcSEcCtD
Methysergide—Paraesthesia—Bupropion—obesity	0.000286	0.00187	CcSEcCtD
Methysergide—Bromocriptine—ADRB1—obesity	0.000284	0.0427	CrCbGaD
Methysergide—Dyspnoea—Bupropion—obesity	0.000284	0.00185	CcSEcCtD
Methysergide—Somnolence—Bupropion—obesity	0.000284	0.00185	CcSEcCtD
Methysergide—Lisuride—HTR2C—obesity	0.000283	0.0425	CrCbGaD
Methysergide—Oedema peripheral—Topiramate—obesity	0.000282	0.00184	CcSEcCtD
Methysergide—Dyspepsia—Bupropion—obesity	0.000281	0.00183	CcSEcCtD
Methysergide—Gastrointestinal disorder—Bupropion—obesity	0.000275	0.00179	CcSEcCtD
Methysergide—Fatigue—Bupropion—obesity	0.000275	0.00179	CcSEcCtD
Methysergide—Constipation—Bupropion—obesity	0.000273	0.00178	CcSEcCtD
Methysergide—Pain—Bupropion—obesity	0.000273	0.00178	CcSEcCtD
Methysergide—Ergotamine—HTR2C—obesity	0.000272	0.0408	CrCbGaD
Methysergide—Asthenia—Orlistat—obesity	0.000271	0.00177	CcSEcCtD
Methysergide—Methylergometrine—HTR2A—obesity	0.000269	0.0403	CrCbGaD
Methysergide—Flushing—Topiramate—obesity	0.000266	0.00173	CcSEcCtD
Methysergide—HTR2A—liver—obesity	0.000264	0.00592	CbGeAlD
Methysergide—Feeling abnormal—Bupropion—obesity	0.000263	0.00171	CcSEcCtD
Methysergide—Asthenia—Sibutramine—obesity	0.000263	0.00171	CcSEcCtD
Methysergide—Bromocriptine—HTR2C—obesity	0.000262	0.0394	CrCbGaD
Methysergide—Gastrointestinal pain—Bupropion—obesity	0.000261	0.0017	CcSEcCtD
Methysergide—Diarrhoea—Orlistat—obesity	0.000259	0.00169	CcSEcCtD
Methysergide—Alopecia—Topiramate—obesity	0.000253	0.00165	CcSEcCtD
Methysergide—Abdominal pain—Bupropion—obesity	0.000252	0.00164	CcSEcCtD
Methysergide—Body temperature increased—Bupropion—obesity	0.000252	0.00164	CcSEcCtD
Methysergide—Diarrhoea—Sibutramine—obesity	0.00025	0.00163	CcSEcCtD
Methysergide—Dizziness—Orlistat—obesity	0.00025	0.00163	CcSEcCtD
Methysergide—Dizziness—Sibutramine—obesity	0.000242	0.00158	CcSEcCtD
Methysergide—Back pain—Topiramate—obesity	0.000241	0.00157	CcSEcCtD
Methysergide—Vomiting—Orlistat—obesity	0.00024	0.00157	CcSEcCtD
Methysergide—Rash—Orlistat—obesity	0.000238	0.00155	CcSEcCtD
Methysergide—Dermatitis—Orlistat—obesity	0.000238	0.00155	CcSEcCtD
Methysergide—Lisuride—DRD2—obesity	0.000233	0.035	CrCbGaD
Methysergide—Vomiting—Sibutramine—obesity	0.000233	0.00152	CcSEcCtD
Methysergide—Ill-defined disorder—Topiramate—obesity	0.000231	0.00151	CcSEcCtD
Methysergide—Rash—Sibutramine—obesity	0.000231	0.0015	CcSEcCtD
Methysergide—Dermatitis—Sibutramine—obesity	0.000231	0.0015	CcSEcCtD
Methysergide—Asthenia—Bupropion—obesity	0.000229	0.00149	CcSEcCtD
Methysergide—Nausea—Orlistat—obesity	0.000225	0.00146	CcSEcCtD
Methysergide—Malaise—Topiramate—obesity	0.000225	0.00146	CcSEcCtD
Methysergide—Ergotamine—DRD2—obesity	0.000224	0.0336	CrCbGaD
Methysergide—Diarrhoea—Bupropion—obesity	0.000218	0.00142	CcSEcCtD
Methysergide—Nausea—Sibutramine—obesity	0.000217	0.00142	CcSEcCtD
Methysergide—Bromocriptine—DRD2—obesity	0.000216	0.0324	CrCbGaD
Methysergide—Convulsion—Topiramate—obesity	0.000216	0.00141	CcSEcCtD
Methysergide—Myalgia—Topiramate—obesity	0.000212	0.00138	CcSEcCtD
Methysergide—Arthralgia—Topiramate—obesity	0.000212	0.00138	CcSEcCtD
Methysergide—Chest pain—Topiramate—obesity	0.000212	0.00138	CcSEcCtD
Methysergide—Dizziness—Bupropion—obesity	0.000211	0.00137	CcSEcCtD
Methysergide—Discomfort—Topiramate—obesity	0.000209	0.00136	CcSEcCtD
Methysergide—Oedema—Topiramate—obesity	0.000203	0.00132	CcSEcCtD
Methysergide—Vomiting—Bupropion—obesity	0.000203	0.00132	CcSEcCtD
Methysergide—Rash—Bupropion—obesity	0.000201	0.00131	CcSEcCtD
Methysergide—Dermatitis—Bupropion—obesity	0.000201	0.00131	CcSEcCtD
Methysergide—Thrombocytopenia—Topiramate—obesity	0.000199	0.0013	CcSEcCtD
Methysergide—Tachycardia—Topiramate—obesity	0.000198	0.00129	CcSEcCtD
Methysergide—Nausea—Bupropion—obesity	0.000189	0.00123	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Topiramate—obesity	0.000185	0.00121	CcSEcCtD
Methysergide—Insomnia—Topiramate—obesity	0.000184	0.0012	CcSEcCtD
Methysergide—Paraesthesia—Topiramate—obesity	0.000183	0.00119	CcSEcCtD
Methysergide—Dyspnoea—Topiramate—obesity	0.000181	0.00118	CcSEcCtD
Methysergide—Somnolence—Topiramate—obesity	0.000181	0.00118	CcSEcCtD
Methysergide—Lisuride—HTR2A—obesity	0.00018	0.0271	CrCbGaD
Methysergide—Dyspepsia—Topiramate—obesity	0.000179	0.00117	CcSEcCtD
Methysergide—Gastrointestinal disorder—Topiramate—obesity	0.000175	0.00114	CcSEcCtD
Methysergide—Fatigue—Topiramate—obesity	0.000175	0.00114	CcSEcCtD
Methysergide—Pain—Topiramate—obesity	0.000174	0.00113	CcSEcCtD
Methysergide—Constipation—Topiramate—obesity	0.000174	0.00113	CcSEcCtD
Methysergide—Ergotamine—HTR2A—obesity	0.000173	0.026	CrCbGaD
Methysergide—Feeling abnormal—Topiramate—obesity	0.000167	0.00109	CcSEcCtD
Methysergide—Bromocriptine—HTR2A—obesity	0.000167	0.0251	CrCbGaD
Methysergide—Gastrointestinal pain—Topiramate—obesity	0.000166	0.00108	CcSEcCtD
Methysergide—Abdominal pain—Topiramate—obesity	0.000161	0.00105	CcSEcCtD
Methysergide—Body temperature increased—Topiramate—obesity	0.000161	0.00105	CcSEcCtD
Methysergide—Asthenia—Topiramate—obesity	0.000146	0.00095	CcSEcCtD
Methysergide—Diarrhoea—Topiramate—obesity	0.000139	0.000906	CcSEcCtD
Methysergide—Dizziness—Topiramate—obesity	0.000134	0.000876	CcSEcCtD
Methysergide—Vomiting—Topiramate—obesity	0.000129	0.000842	CcSEcCtD
Methysergide—Rash—Topiramate—obesity	0.000128	0.000835	CcSEcCtD
Methysergide—Dermatitis—Topiramate—obesity	0.000128	0.000834	CcSEcCtD
Methysergide—Nausea—Topiramate—obesity	0.000121	0.000786	CcSEcCtD
Methysergide—HTR2C—Signaling Pathways—PRKCD—obesity	4.43e-06	2.36e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF1—obesity	4.4e-06	2.34e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AKT2—obesity	4.39e-06	2.34e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOB—obesity	4.38e-06	2.33e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR2A—obesity	4.36e-06	2.32e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—C3—obesity	4.35e-06	2.32e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PIK3CD—obesity	4.35e-06	2.31e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PIK3CD—obesity	4.34e-06	2.31e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR2A—obesity	4.34e-06	2.31e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—C3—obesity	4.33e-06	2.3e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PIK3CD—obesity	4.31e-06	2.29e-05	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—PIK3CA—obesity	4.3e-06	2.29e-05	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—PIK3CA—obesity	4.3e-06	2.29e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SERPINE1—obesity	4.3e-06	2.29e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—POMC—obesity	4.29e-06	2.28e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SERPINE1—obesity	4.29e-06	2.28e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—STAT3—obesity	4.28e-06	2.28e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL5—obesity	4.27e-06	2.27e-05	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—PIK3CA—obesity	4.27e-06	2.27e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—INS—obesity	4.27e-06	2.27e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SERPINE1—obesity	4.26e-06	2.27e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PIK3CD—obesity	4.22e-06	2.25e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MYC—obesity	4.22e-06	2.24e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TGFB1—obesity	4.21e-06	2.24e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCL2—obesity	4.2e-06	2.23e-05	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—PIK3CA—obesity	4.18e-06	2.22e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TYK2—obesity	4.18e-06	2.22e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LPL—obesity	4.18e-06	2.22e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SERPINE1—obesity	4.18e-06	2.22e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TYK2—obesity	4.18e-06	2.22e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TYK2—obesity	4.15e-06	2.21e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FOXO1—obesity	4.15e-06	2.21e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—RHOA—obesity	4.15e-06	2.2e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IRS2—obesity	4.14e-06	2.2e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—RHOA—obesity	4.14e-06	2.2e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RPS6KB1—obesity	4.14e-06	2.2e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AGT—obesity	4.14e-06	2.2e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF1—obesity	4.13e-06	2.2e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AKT2—obesity	4.13e-06	2.2e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IRS2—obesity	4.12e-06	2.19e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AGT—obesity	4.12e-06	2.19e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—RHOA—obesity	4.11e-06	2.19e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PIK3R1—obesity	4.1e-06	2.18e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NOS3—obesity	4.1e-06	2.18e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PIK3CB—obesity	4.1e-06	2.18e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PIK3R1—obesity	4.1e-06	2.18e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NOS3—obesity	4.1e-06	2.18e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PIK3R1—obesity	4.07e-06	2.17e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NOS3—obesity	4.07e-06	2.17e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TYK2—obesity	4.06e-06	2.16e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—LEP—obesity	4.05e-06	2.16e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APOE—obesity	4.05e-06	2.16e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APOE—obesity	4.03e-06	2.14e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—LEP—obesity	4.03e-06	2.14e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—RHOA—obesity	4.03e-06	2.14e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CAV1—obesity	4.02e-06	2.14e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APOA1—obesity	4.01e-06	2.13e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CAV1—obesity	4e-06	2.13e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PIK3R1—obesity	3.99e-06	2.12e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NOS3—obesity	3.99e-06	2.12e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APOA1—obesity	3.99e-06	2.12e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MYC—obesity	3.98e-06	2.12e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TGFB1—obesity	3.97e-06	2.11e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PIK3CD—obesity	3.97e-06	2.11e-05	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—PIK3CA—obesity	3.93e-06	2.09e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SERPINE1—obesity	3.92e-06	2.09e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—PIK3CA—obesity	3.91e-06	2.08e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—PIK3CA—obesity	3.9e-06	2.08e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—PIK3CA—obesity	3.88e-06	2.06e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ESR1—obesity	3.87e-06	2.06e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ESR1—obesity	3.85e-06	2.05e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKCD—obesity	3.85e-06	2.05e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—F2—obesity	3.82e-06	2.03e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PRKCB—obesity	3.82e-06	2.03e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TYK2—obesity	3.82e-06	2.03e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PRKCB—obesity	3.8e-06	2.02e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—F2—obesity	3.8e-06	2.02e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—PIK3CA—obesity	3.8e-06	2.02e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PIK3CB—obesity	3.79e-06	2.01e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MTOR—obesity	3.79e-06	2.01e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—RHOA—obesity	3.78e-06	2.01e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MTOR—obesity	3.78e-06	2.01e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PIK3CB—obesity	3.78e-06	2.01e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—BAD—obesity	3.78e-06	2.01e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—C3—obesity	3.76e-06	2e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MTOR—obesity	3.76e-06	2e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PIK3CB—obesity	3.76e-06	2e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—BAD—obesity	3.76e-06	2e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PIK3R1—obesity	3.75e-06	1.99e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NOS3—obesity	3.75e-06	1.99e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PIK3CB—obesity	3.68e-06	1.96e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MTOR—obesity	3.68e-06	1.96e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3CG—obesity	3.66e-06	1.95e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3CG—obesity	3.64e-06	1.94e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IRS1—obesity	3.62e-06	1.92e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IRS1—obesity	3.6e-06	1.91e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PIK3CA—obesity	3.58e-06	1.91e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IRS2—obesity	3.58e-06	1.9e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AGT—obesity	3.57e-06	1.9e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—PIK3CA—obesity	3.57e-06	1.9e-05	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—AKT1—obesity	3.52e-06	1.87e-05	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—AKT1—obesity	3.51e-06	1.87e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOE—obesity	3.5e-06	1.86e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LEP—obesity	3.5e-06	1.86e-05	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—AKT1—obesity	3.49e-06	1.86e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—obesity	3.48e-06	1.85e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CAV1—obesity	3.47e-06	1.85e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—obesity	3.46e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—INS—obesity	3.46e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOA1—obesity	3.46e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—obesity	3.46e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PIK3CB—obesity	3.46e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MTOR—obesity	3.46e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—obesity	3.46e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—INS—obesity	3.45e-06	1.83e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—obesity	3.43e-06	1.83e-05	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—AKT1—obesity	3.42e-06	1.82e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL2—obesity	3.41e-06	1.81e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL2—obesity	3.39e-06	1.8e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PIK3CA—obesity	3.38e-06	1.8e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—obesity	3.36e-06	1.79e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF1—obesity	3.35e-06	1.78e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKT2—obesity	3.35e-06	1.78e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ESR1—obesity	3.34e-06	1.78e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF1—obesity	3.33e-06	1.77e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKT2—obesity	3.33e-06	1.77e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKCB—obesity	3.3e-06	1.76e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—F2—obesity	3.3e-06	1.76e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MMP9—obesity	3.29e-06	1.75e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MMP9—obesity	3.29e-06	1.75e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MMP9—obesity	3.27e-06	1.74e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—BAD—obesity	3.26e-06	1.74e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3CD—obesity	3.22e-06	1.71e-05	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AKT1—obesity	3.21e-06	1.71e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MAPK8—obesity	3.2e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3CD—obesity	3.2e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MMP9—obesity	3.2e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MAPK8—obesity	3.2e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AKT1—obesity	3.19e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AKT1—obesity	3.19e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—PIK3CA—obesity	3.19e-06	1.69e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SERPINE1—obesity	3.18e-06	1.69e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MAPK8—obesity	3.18e-06	1.69e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—obesity	3.17e-06	1.69e-05	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—PIK3CA—obesity	3.17e-06	1.69e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AKT1—obesity	3.17e-06	1.69e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SERPINE1—obesity	3.16e-06	1.68e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3CG—obesity	3.16e-06	1.68e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—obesity	3.16e-06	1.68e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IRS1—obesity	3.12e-06	1.66e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MAPK8—obesity	3.11e-06	1.65e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AKT1—obesity	3.1e-06	1.65e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TYK2—obesity	3.09e-06	1.65e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TYK2—obesity	3.08e-06	1.64e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—RHOA—obesity	3.07e-06	1.63e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—RHOA—obesity	3.05e-06	1.62e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3R1—obesity	3.04e-06	1.62e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOS3—obesity	3.04e-06	1.62e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3R1—obesity	3.02e-06	1.61e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOS3—obesity	3.02e-06	1.61e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—obesity	3.01e-06	1.6e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MMP9—obesity	3e-06	1.6e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—obesity	2.99e-06	1.59e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—INS—obesity	2.99e-06	1.59e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL2—obesity	2.94e-06	1.57e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—STAT3—obesity	2.93e-06	1.56e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AKT1—obesity	2.93e-06	1.56e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—STAT3—obesity	2.92e-06	1.55e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MAPK8—obesity	2.92e-06	1.55e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AKT1—obesity	2.91e-06	1.55e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—STAT3—obesity	2.9e-06	1.54e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF1—obesity	2.89e-06	1.54e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PIK3CA—obesity	2.89e-06	1.54e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKT2—obesity	2.89e-06	1.54e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PIK3CA—obesity	2.88e-06	1.53e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—STAT3—obesity	2.84e-06	1.51e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3CB—obesity	2.8e-06	1.49e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MTOR—obesity	2.8e-06	1.49e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3CB—obesity	2.79e-06	1.48e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MTOR—obesity	2.79e-06	1.48e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3CD—obesity	2.78e-06	1.48e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AKT1—obesity	2.76e-06	1.47e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—PIK3CA—obesity	2.75e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SERPINE1—obesity	2.75e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MYC—obesity	2.72e-06	1.45e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MYC—obesity	2.72e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TGFB1—obesity	2.71e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TGFB1—obesity	2.71e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MYC—obesity	2.7e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TGFB1—obesity	2.69e-06	1.43e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TYK2—obesity	2.67e-06	1.42e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—STAT3—obesity	2.67e-06	1.42e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RHOA—obesity	2.65e-06	1.41e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MYC—obesity	2.64e-06	1.41e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TGFB1—obesity	2.64e-06	1.4e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOS3—obesity	2.62e-06	1.4e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3R1—obesity	2.62e-06	1.4e-05	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AKT1—obesity	2.6e-06	1.38e-05	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AKT1—obesity	2.59e-06	1.38e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—obesity	2.56e-06	1.36e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—obesity	2.55e-06	1.36e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PIK3CA—obesity	2.5e-06	1.33e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MYC—obesity	2.48e-06	1.32e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TGFB1—obesity	2.48e-06	1.32e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MMP9—obesity	2.44e-06	1.3e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MMP9—obesity	2.42e-06	1.29e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MTOR—obesity	2.42e-06	1.29e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3CB—obesity	2.42e-06	1.29e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MAPK8—obesity	2.37e-06	1.26e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AKT1—obesity	2.36e-06	1.26e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MAPK8—obesity	2.36e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AKT1—obesity	2.35e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PIK3CA—obesity	2.31e-06	1.23e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PIK3CA—obesity	2.31e-06	1.23e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PIK3CA—obesity	2.29e-06	1.22e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AKT1—obesity	2.25e-06	1.2e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PIK3CA—obesity	2.24e-06	1.19e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—obesity	2.21e-06	1.18e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—STAT3—obesity	2.17e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—STAT3—obesity	2.16e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PIK3CA—obesity	2.11e-06	1.12e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MMP9—obesity	2.11e-06	1.12e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MAPK8—obesity	2.05e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—obesity	2.04e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—obesity	2.04e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AKT1—obesity	2.04e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—obesity	2.03e-06	1.08e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MYC—obesity	2.01e-06	1.07e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TGFB1—obesity	2.01e-06	1.07e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MYC—obesity	2e-06	1.07e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TGFB1—obesity	2e-06	1.06e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—obesity	1.99e-06	1.06e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AKT1—obesity	1.89e-06	1e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AKT1—obesity	1.88e-06	1e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—STAT3—obesity	1.87e-06	9.95e-06	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AKT1—obesity	1.87e-06	9.95e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—obesity	1.87e-06	9.92e-06	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AKT1—obesity	1.83e-06	9.75e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MYC—obesity	1.74e-06	9.25e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TGFB1—obesity	1.74e-06	9.23e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AKT1—obesity	1.72e-06	9.16e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3CA—obesity	1.71e-06	9.09e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3CA—obesity	1.7e-06	9.04e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—obesity	1.51e-06	8.05e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—obesity	1.51e-06	8.01e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3CA—obesity	1.48e-06	7.85e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKT1—obesity	1.4e-06	7.43e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKT1—obesity	1.39e-06	7.39e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—obesity	1.31e-06	6.95e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKT1—obesity	1.21e-06	6.41e-06	CbGpPWpGaD
